Rchr

J-GLOBAL ID：200901011048683525 Update date: Sep. 13, 2022

Okumura Hirokazu

オクムラヒロカズ | Okumura Hirokazu

Affiliation and department：

Research field (1)： Hematology and oncology

Research keywords (2)：化学療法 , Hematology

Research theme for competitive and other funds (2)：

1997 - 造血器腫瘍に対する化学療法
1997 - Chemotherapy for hematological malignancy

MISC (37)：

J Ozaki, H Okumura, K Iwamoto, S Shimadoi, S Yamanaka, S Ohtake, S Nakao. Refractory Crow-Fukase syndrome (POEMS syndrome) successfully treated with high-dose melphalan followed by autologous peripheral blood stem cell transplantation. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2004. 79. 1. 95-99
J Ozaki, H Okumura, K Iwamoto, S Shimadoi, S Yamanaka, S Ohtake, S Nakao. Refractory Crow-Fukase syndrome (POEMS syndrome) successfully treated with high-dose melphalan followed by autologous peripheral blood stem cell transplantation. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2004. 79. 1. 95-99
Jiebin Zhu, Hirokazu Okumura, Shigeki Ohtake, Shinobu Nakamura, Shinji Nakao. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system. Oncology Reports. 2003. 10. 3. 705-709
JB Zhu, H Okumura, S Ohtake, S Nakamura, S Nakao. The molecular mechanism of arsenic trioxide-induced apoptosis and oncosis in leukemia/lymphoma cell lines. ACTA HAEMATOLOGICA. 2003. 110. 1. 1-10
Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system. ONCOLOGY REPORTS. 2003. 10. 705-709

ｍore...

Education (2)：

- 1987 Kanazawa University
- 1987 Kanazawa University Faculty of Medicine

Professional career (1)：

博士(医学) (金沢大学)

Association Membership(s) (6)：

日本輸血学会 , 日本造血細胞移植学会 , 日本臨床血液学会 , 日本血液学会 , 日本癌学会 , 日本内科学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM